Coherent Trial Acceleration

Coherent Trial Acceleration
CTMG has emerged as the first resource in the drug development industry to understand and to correct perhaps the biggest remaining challenge in Stage 2 - 3 trials: the essential impenetrable barrier between the Sponsor and the PI Site.
Read More...
• Powerful New Evidence • On-Site Patient Enrollment Experts • Consistent, Sustained Recruitment Strategies • Continuous Validation of Patient Profiles • Front End Discipline of FDA Standards As noted in … [READ MORE]

• The murky space beyond the “Barrier” • Watch out for the data trap Can You Spot The Huge Trapdoor In Your Clinical Trial? ***Click the Images to the right for an Enlarged Captioned View*** CTMG has … [READ MORE]

• Insufficiency Of The Deeply Flawed SMO Model • What’s It All About: The FDA! • Why CTMG? ***Click the Images to the right for a Enlarged Captioned View*** The large reason for the "Black Hole" has been … [READ MORE]